Interpace Diagnostics Group, Inc. (58) | Human Resources (14)

Browse by Subcategory

Recent Contracts

Employment agreement entered into May 10, 2021, effective February 1, 2021, between Thomas Freeburg and the Company (Filed With SEC on May 11, 2021)
Severance Agreement and General Release, dated January 31, 2021, by and between the Company and Fred Knechtel (Filed With SEC on February 4, 2021)
Separation and Consulting Agreement and General Release, dated November 23, 2020, between Jack E. Stover and Interpace Biosciences, Inc (Filed With SEC on November 25, 2020)
Amendment to the Interpace Biosciences, Inc. 2019 Equity Incentive Plan (Filed With SEC on June 26, 2020)
Transition Services Agreement, dated July 15, 2019, by and between Interpace BioPharma, Inc. and Cancer Genetics, Inc (Filed With SEC on July 19, 2019)
Employment Separation Agreement between Interpace Diagnostics, LLC and Gregory Richard, effective as of March 25, 2015 (Filed With SEC on March 21, 2019)
Employment Agreement, dated November 23, 2020, between Thomas W. Burnell and Interpace Biosciences, Inc (Filed With SEC on November 25, 2020)
Form of Interpace Biosciences, Inc. 2019 Equity Incentive Plan Restricted Stock Unit And Restricted Stock Unit Agreement (Filed With SEC on June 26, 2020)
Severance and Consulting Agreement and General Release, dated January 29, 2020, by and between Interpace Biosciences, Inc. and James Early (Filed With SEC on January 31, 2020)
Employment Agreement, dated as of January 29, 2020, by and between Interpace Biosciences, Inc. and Fred Knechtel (Filed With SEC on January 31, 2020)
First Amendment to Amended and Restated Employment Agreement, dated January 29, 2020, by and between Interpace Biosciences, Inc. and Jack E. Stover (Filed With SEC on January 31, 2020)
Interpace Biosciences, Inc. 2019 Equity Incentive Plan (Filed With SEC on November 14, 2019)
Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement under the Interpace Biosciences, Inc. 2019 Equity Incentive Plan (Filed With SEC on November 14, 2019)
Form of Stock Option Grant Notice and Stock Option Agreement under the Interpace Biosciences, Inc. 2019 Equity Incentive Plan (Filed With SEC on November 14, 2019)